21. Cifelli C, Rose RA, Zhang H, Voigtlaender-Bolz J, Bolz SS, et al. (2008) RGS4 Regulates Parasympathetic Signaling and Heart Rate Control in the Sinoatrial Node. Circ Res 103:527–535. 22. Rose RA, Lomax AE, Kondo CS, Anand-Srivastava MB, Giles WR (2004) Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor. Am J Physiol 286:H1970–H1977. 23. Rose RA, Sellan M, Simpson JA, Izaddoustdar F, Cifelli C, et al. (2011) Iron Overload Decreases CaV1.3-Dependent L-Type Ca2+ Currents Leading to Bradycardia, Altered Electrical Conduction, and Atrial Fibrillation. Circ Arrhythm Electrophysiol 4:733–742. 24. Marionneau C, Couette B, Liu J, Li H, Mangoni ME, et al. (2005) Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. J Physiol 562:223–234. 25. Mery PF, Pavoine C, Pecker F, Fischmeister R (1995) Erythro-9-(2-hydroxy-3- nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol 48:121–130. 26. Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366–398. 27. Rivet-Bastide M, Vandecasteele G, Hatem S, Verde I, Benardeau A, et al. (1997) cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. J Clin Invest 99:2710–2718. 28. Vandecasteele G, Verde I, Rucker-Martin C, Donzeau-Gouge P, Fischmeister R (2001) Cyclic GMP regulation of the L-type Ca2+ channel current in human atrial myocytes. J Physiol 533:329–340. 29. Bers DM, Perez-Reyes E (1999) Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 42:339–360. 30. Marban E (2002) Cardiac channelopathies. Nature 415:213–218. 31. Richter W, Xie M, Scheitrum C, Krall J, Movsesian MA, et al. (2011) Conserved expression and functions of PDE4 in rodent and human heart. Basic Res Cardiol 106:249–262. 32. Beca S, schars-Sobbi R, Panama BK, Backx PH (2011) Regulation of murine cardiac function by phosphodiesterases type 3 and 4. Curr Opin Pharmacol 11:714–719. 33. Kerfant BG, Rose RA, Sun H, Backx PH (2006) Phosphoinositide 3-kinase? Regulates Cardiac Contractility by Locally Controlling Cyclic Adenosine Monophosphate Levels. Trends Cardiovasc Med 16:250–256. 34. Vinogradova TM, Sirenko S, Lyashkov AE, Younes A, Li Y, et al. (2008) Constitutive phosphodiesterase activity restricts spontaneous beating rate of cardiac pacemaker cells by suppressing local Ca2+ releases. Circ Res 102:761– 769. 35. Hata T, Nishimura M, Ogino K, Uchiyama H, Watanabe Y (1998) Electrophysiological effects of amrinone on the automaticity and membrane current system of the rabbit sinoatrial node cells. Heart Vessels 13:114–121. PDE Effects in Sinoatrial Node and Atrium 36. Orito K, Takase H, Fujiki H, Mori T (1996) Effects of toborinone (OPC-18790), a new positive inotropic agent, on action potential in guinea pig sinoatrial node: compared with milrinone and E-4031. Jpn J Pharmacol 72:79–82. 37. Kaumann AJ (2011) Phosphodiesterases reduce spontaneous sinoatrial beating but not the ‘fight or flight’ tachycardia elicited by agonists through Gs-protein- coupled receptors. Trends Pharmacol Sci 32:377–383. 38. Kirstein M, Rivet-Bastide M, Hatem S, Benardeau A, Mercadier JJ, et al. (1995) Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95:794–802. 39. Molina CE, Leroy J, Richter W, Xie M, Scheitrum C, et al. (2012) Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol 59:2182–2190. 40. DiFrancesco D, Tromba C (1988) Muscarinic control of the hyperpolarization- activated current (if) in rabbit sino-atrial node myocytes. J Physiol 405:493–510. 41. Shimizu K, Shintani Y, Ding WG, Matsuura H, Bamba T (2002) Potentiation of slow component of delayed rectifier K+ current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G. Br J Pharmacol 137:127–137. 42. Clark RB, Mangoni ME, Lueger A, Couette B, Nargeot J, et al. (2004) A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells. Am J Physiol Heart Circ Physiol 286:H1757– H1766. 43. Hagiwara N, Irisawa H, Kameyama M (1988) Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 395:233–253. 44. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, et al. (2006) Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/a1G T-type calcium channels. Circ Res 98:1422–1430. 45. Bean BP (1985) Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol 86:1–30. 46. Ertel SI, Ertel EA, Clozel JP (1997) T-type Ca2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovasc Drugs Ther 11:723–739. 47. Hess P (1988) Elementary properties of cardiac calcium channels: a brief review. Can J Physiol Pharmacol 66:1218–1223. 48. Hirano Y, Fozzard HA, January CT (1989) Characteristics of L- and T-type Ca2+ currents in canine cardiac Purkinje cells. Am J Physiol 256:H1478–H1492. 49. Vandeput F, Wolda SL, Krall J, Hambleton R, Uher L, et al. (2007) Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes. J Biol Chem 282:32749–32757. 50. Zhang M, Kass DA (2011) Phosphodiesterases and cardiac cGMP: evolving roles and controversies. Trends Pharmacol Sci 32:360–365. PLOS ONE | www.plosone.org 12 October 2012 | Volume 7 | Issue 10 | e47652